MUC1 and triple-negative breast carcinoma: Liu et al created nanoparticles to design an mRNA vaccine encoding the tumor antigen MUC1 (Mucin 1, Cell Surface Associated) into DCs to activate and increase T cells in triple-negative breast cancer studies.